tert-Butyl (3R,4S)-4-amino-3-methylpiperidine-1-carboxylate, 98%, 250mg

(R)-1-(3-Aminopyrrolidin-1-yl)-2,2-dimethylpropan-1-one, 95.0%, 1g

2-AMINO-2-(2-FLUOROPHENYL)ETHANOL, 95.0%, 250mg

8-hydroxy-1,2-dihydroisoquinolin-1-one, 97%, 1g

2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one, 98%, 1g

RAFFINOSE, 95%, 5g

N-(4-ethylbenzyl)-1-propanamine hydrochloride, 95.0%, 1g

1-(3,4-Dimethylphenyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 1g

Cartella di preparazione con coperchio incernierato in due parti e chiusura 10 pz

(6-(Piperidin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 97%, 1g

Benzo[d]thiazole-4-carbaldehyde, 97.0%, 1g

Acetyl-L-aspartic acid a-methyl ester, 98.0%, 5g

2-Chloro-3-[(4-fluorobenzyl)oxy]pyridine, 93.0%, 500mg